Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    19357394 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
Condition: Acute Myeloid Leukemia
Intervention:
2 Recruiting Molecular Disease Profile of Hematological Malignancies
Condition: Hematological Malignancies
Intervention:
3 Active, not recruiting Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Azacitidine;   Drug: Vorinostat

Study has passed its completion date and status has not been verified in more than two years.